Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
European Travel Objections for 2024 - 2Holiday spots Well known With Americans In 2024
- 3Air Canada CEO To Resign After Backlash—Here’s Why Communication Skills Is Now A Leadership Requirement
- 4'The Real Housewives of Rhode Island' 1st teaser trailer unveiled: Which Bachelor Nation star is part of the cast? And when does it premiere?
- 5Record-breaking 'space laser' erupts from merging galaxies 8 billion light-years away
- Transform the daily grind to make life more interesting – a philosopher shares 3 strategies to help you attain the good life
- Exploring ways to reduce the impact of space junk on Earth
- Explainer-What will change with the US reclassification of marijuana?
- Health insurance premiums rose nearly 3x the rate of worker earnings over the past 25 years
- ‘Risk children’s lives for some extra manpower’: IRGC recruits 12 year olds to fill personnel gaps
- German mid-sized firms gloomy on outlook, survey finds
- National health ranking puts Georgia near bottom of list. Here's why
- 'Home Alone' actor Joe Pesci said 'no' to this stunt until he saw a 9-year-old girl do it, says director Chris Columbus
- Trump awarded 1st FIFA Peace Prize by Gianni Infantino at 2026 World Cup draw
